Method choice is crucial to when seeking answers to biosimilar characterization questions.
Guillaume Tremintin
Advertisement
Guillaume Tremintin is the biopharma market manager for Bruker Daltonics.
Articles by Guillaume Tremintin
Advertisement
Latest Updated Articles
Matching Tools to Biophysical Analysis DemandsPublished: July 1st 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
